Almost anyone can take this quick test for Alzheimer’s without even going to the doctor. It’s a terrible idea.
Denial of coverage for lecanemab will have devastating consequences for millions of patients and families.
On March 22, Weisman and his fellow advisers voted unanimously that the drug was ‘reasonably likely’ to prove beneficial, paving the way for the agency to approve it Tuesday.
Tofersen, an injection treatment for a rare form of ALS, has been approved under the accelerated approval pathway.
The committee convened to discuss tofersen, an experimental injection for treatment of ALS.
Leqembi significantly reduces progression of memory loss in those with Alzheimer’s disease by about 30%.